OpenURL Connection Search

Select item for more details and to access through your institution.

Treatment of hypercalcemia in parathyroid cancer with WR-2721, S-2-(3-aminopropylamino)ethyl-phosphorothioic acid.
Published in:
1985
By:
- Glover, Donna J.;
- Shaw, Leslie;
- Glick, John H.;
- Slatopolsky, Eduardo;
- Weiler, Clare;
- Attie, Maurice;
- Goldfrab, Stanley;
- Glover, D J;
- Shaw, L;
- Glick, J H;
- Slatopolsky, E;
- Weiler, C;
- Attie, M;
- Goldfarb, S
Publication type:
journal article
Reduced serum levels of 1 alpha,25-dihydroxyvitamin D during long-term total parenteral nutrition.
Published in:
1981
By:
- Klein, Gordon L.;
- Horst, Ronald L.;
- Norman, Anthony W.;
- Ament, Marvin E.;
- Slatopolsky, Eduardo;
- Coburn, Jack W.;
- Klein, G L;
- Horst, R L;
- Norman, A W;
- Ament, M E;
- Slatopolsky, E;
- Coburn, J W
Publication type:
journal article
gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses.
Published in:
1997
By:
- Dusso, A S;
- Kamimura, S;
- Gallieni, M;
- Zhong, M;
- Negrea, L;
- Shapiro, S;
- Slatopolsky, E
Publication type:
journal article
Extrarenal production of calcitriol in normal and uremic humans.
Published in:
1991
By:
- Dusso, A S;
- Finch, J;
- Brown, A;
- Ritter, C;
- Delmez, J;
- Schreiner, G;
- Slatopolsky, E
Publication type:
journal article
1α,25-Dihydroxy-3-Epi-vitamin D.
Published in:
Journal of Cellular Biochemistry, 1999, v. 73, n. 1, p. 106, doi. 10.1002/(SICI)1097-4644(19990401)73:1<106::AID-JCB12>3.0.CO;2-Q
By:
- Brown, A.J.;
- Ritter, C.;
- Slatopolsky, E.;
- Muralidharan, K.R.;
- Okamura, W.H.;
- Reddy, G.S.
Publication type:
Article
Serial serum 25-hydroxyvitamin D and mineral homeostasis in very premature infants fed preterm human milk.
Published in:
1985
By:
- Hillman, Laura S.;
- Salmons, Sharon J.;
- Slatopolsky, Eduardo;
- McAlister, William H.;
- Hillman, L S;
- Salmons, S J;
- Slatopolsky, E;
- McAlister, W H
Publication type:
journal article
Serum levels of 1,25-dihydroxyvitamin D in children receiving parenteral nutrition with reduced aluminum content.
Published in:
1985
By:
- Klein, Gordon L.;
- Horst, Ronald L.;
- Alfrey, Allen C.;
- Slatopolsky, Eduardo;
- Klein, G L;
- Horst, R L;
- Alfrey, A C;
- Slatopolsky, E
Publication type:
journal article
Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients.
Published in:
Clinical Nephrology, 2006, v. 65, n. 5, p. 335, doi. 10.5414/CNP65335
By:
- Joist, H. E.;
- Ahya, S. N.;
- Giles, K.;
- Norwood, K.;
- Slatopolsky, E.;
- Coyne, D. W.
Publication type:
Article
The role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism.
Published in:
Nephrology Dialysis Transplantation, 1998, v. 13, p. 3, doi. 10.1093/ndt/13.suppl_3.3
By:
- Slatopolsky, E
Publication type:
Article
RenaGel, a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers.
Published in:
Nephrology Dialysis Transplantation, 1997, v. 12, n. 8, p. 1640, doi. 10.1093/ndt/12.8.1640
By:
- Burke, S K;
- Slatopolsky, E A;
- Goldberg, D I
Publication type:
Article
Modulation of renal osteodystrophy by extrarenal production of calcitriol.
Published in:
1995
By:
- Delmez, James A.;
- Dusso, Adriana S.;
- Slatopolsky, Eduardo;
- Teitelbaum, Steven L.;
- Delmez, J A;
- Dusso, A S;
- Slatopolsky, E;
- Teitelbaum, S L
Publication type:
journal article
Vitamin D therapy and cardiac function in chronic kidney disease.
Published in:
2012
By:
- Slatopolsky E;
- Slatopolsky, Eduardo
Publication type:
commentary
Histamine H2 receptor blockade in patients with hyperparathyroidism.
Published in:
1984
By:
- Cunningham, John;
- Segre, Gino;
- Slatopolsky, Eduardo;
- Cunningham, J;
- Segre, G;
- Slatopolsky, E
Publication type:
journal article
Proceedings: Pathogenesis and Treatment of Renal Osteodystrophy.
Published in:
Blood Purification, 2003, v. 21, n. 4/5, p. 318, doi. 10.1159/000072552
By:
- E. Slatopolsky;
- E. Gonzalez;
- K. Martin
Publication type:
Article
Differential effects of vitamin D receptor activators on vascular calcification in uremic rats.
Published in:
Kidney International, 2007, v. 72, n. 6, p. 709, doi. 10.1038/sj.ki.5002406
By:
- Mizobuchi, M.;
- Finch, J. L.;
- Martin, D. R.;
- Slatopolsky, E.
Publication type:
Article
Response to ‘PTH synthesis suppression by 25(OH)2 vit D3’.
Published in:
2007
By:
- Brown, A. J.;
- Slatopolsky, E.
Publication type:
Letter
Response to enlightenment on liver lanthanum exposure.
Published in:
2006
By:
- Slatopolsky, E A;
- Liapis, H;
- Finch, J
Publication type:
Letter
Response to ‘Lanthanum data in perspective’.
Published in:
2006
By:
- Slatopolsky, E;
- Liapis, H;
- Finch, J
Publication type:
Letter
25-Hydroxyvitamin D3 suppresses PTH synthesis and secretion by bovine parathyroid cells.
Published in:
Kidney International, 2006, v. 70, n. 4, p. 654, doi. 10.1038/sj.ki.5000394
By:
- Ritter, C. S.;
- Armbrecht, H. J.;
- Slatopolsky, E.;
- Brown, A. J.
Publication type:
Article
Pathogenic mechanisms for parathyroid hyperplasia.
Published in:
Kidney International, 2006, v. 70, p. S8, doi. 10.1038/sj.ki.5001595
By:
- Dusso, A.S.;
- Sato, T.;
- Arcidiacono, M.V.;
- Alvarez-Hernandez, D.;
- Yang, J.;
- Gonzalez-Suarez, I.;
- Tominaga, Y.;
- Slatopolsky, E.
Publication type:
Article
Pathogenic mechanisms for parathyroid hyperplasia.
Published in:
2006
By:
- Dusso AS;
- Sato T;
- Arcidiacono MV;
- Alvarez-Hernandez D;
- Yang J;
- Gonzalez-Suarez I;
- Tominaga Y;
- Slatopolsky E
Publication type:
Journal Article
22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
Published in:
1999
By:
- MONIER-FAUGERE, MARIE-CLAUDE;
- GENG, ZHAOPO;
- FRIEDLER, ROBERT M.;
- QI, QUANLE;
- KUBODERA, NOBORU;
- SLATOPOLSKY, EDUARDO;
- MALLUCHE, HARTMUT H.;
- Malluche, Hartmut H.;
- Monier-Faugere, M C;
- Geng, Z;
- Friedler, R M;
- Qi, Q;
- Kubodera, N;
- Slatopolsky, E;
- Malluche, H H
Publication type:
journal article
Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study.
Published in:
1996
By:
- Delmez, James A.;
- Kelber, Jacobo;
- Norword, Kathryn Y.;
- Giles, Karla S.;
- Slatopolsky, Eduardo;
- Delmez, J A;
- Kelber, J;
- Norword, K Y;
- Giles, K S;
- Slatopolsky, E
Publication type:
journal article
Pathogenic mechanisms for parathyroid hyperplasia.
Published in:
Kidney International Supplement, 2006, n. 102, p. S8, doi. 10.1038/sj.ki.5001595
By:
- Dusso, A S;
- Sato, T;
- Arcidiacono, M V;
- Alvarez-Hernandez, D;
- Yang, J;
- Gonzalez-Suarez, I;
- Tominaga, Y;
- Slatopolsky, E
Publication type:
Article

Found: 24

Treatment of hypercalcemia in parathyroid cancer with WR-2721, S-2-(3-aminopropylamino)ethyl-phosphorothioic acid.

Reduced serum levels of 1 alpha,25-dihydroxyvitamin D during long-term total parenteral nutrition.

gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses.

Extrarenal production of calcitriol in normal and uremic humans.

1α,25-Dihydroxy-3-Epi-vitamin D.

Serial serum 25-hydroxyvitamin D and mineral homeostasis in very premature infants fed preterm human milk.

Serum levels of 1,25-dihydroxyvitamin D in children receiving parenteral nutrition with reduced aluminum content.

Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients.

The role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism.

RenaGel, a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers.

Modulation of renal osteodystrophy by extrarenal production of calcitriol.

Vitamin D therapy and cardiac function in chronic kidney disease.

Histamine H2 receptor blockade in patients with hyperparathyroidism.

Proceedings: Pathogenesis and Treatment of Renal Osteodystrophy.

Differential effects of vitamin D receptor activators on vascular calcification in uremic rats.

Response to ‘PTH synthesis suppression by 25(OH)<sub>2</sub> vit D<sub>3</sub>’.

Response to enlightenment on liver lanthanum exposure.

Response to ‘Lanthanum data in perspective’.

25-Hydroxyvitamin D<sub>3</sub> suppresses PTH synthesis and secretion by bovine parathyroid cells.

Pathogenic mechanisms for parathyroid hyperplasia.

Pathogenic mechanisms for parathyroid hyperplasia.

22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.

Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study.

Pathogenic mechanisms for parathyroid hyperplasia.